Koneksa Health, Author at Koneksa Health

Koneksa Announces Clinical Pipeline of Validated Digital Biomarkers to Accelerate Life Sciences Research

By Koneksa HealthNews

NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company developing evidence-based validated digital biomarkers, today announced the launch of its clinical pipeline featuring biomarkers across neuroscience, oncology, respiratory, and other therapeutic areas....

October 25, 2022

Koneksa Awarded a Grant from The Michael J. Fox Foundation to Evaluate Disease Progression Using Digital Measures in Parkinson’s Disease

By Koneksa HealthNews

NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company pioneering digital biomarkers, today announced The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a second research grant to evaluate Parkinson’s...

August 8, 2022

Koneksa and Northwestern University Awarded a Grant from The Michael J. Fox Foundation to Investigate Speech Symptoms in Parkinson’s Disease

By Koneksa HealthNews

NEW YORK–(BUSINESS WIRE)–Koneksa, a healthcare technology company pioneering digital biomarkers, announced today that it has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF)...

June 16, 2022

Aural Analytics and Koneksa Announce Partnership to Support Clinical Trials Using Speech Analytics

By Koneksa HealthNews

PHOENIX–(BUSINESS WIRE)–Aural Analytics, Inc., a leader in clinical-grade speech analytics, announced today a partnership with Koneksa, a leader in digital biomarker development, to further strengthen its platform and research capabilities...

June 14, 2022

Koneksa Raises $45M Series C Financing to Accelerate Expansion of Digital Biomarker Platform

By Koneksa HealthNews

NEW YORK–(BUSINESS WIRE)–Koneksa, the leader in designing and validating digital biomarkers to accelerate drug development, announced today the completion of a $45M Series C financing round, led by AyurMaya, an...

February 7, 2022

Koneksa Broadens Multi-Year CNS Research Collaboration with Sanofi Digital Clinical Trial Collaboration Expands to Multiple Sclerosis

By Koneksa HealthNews

NEW YORK – November 3, 2021 – Koneksa, the leader in developing and implementing patient-centric digital biomarkers for drug development, today announced that Sanofi, one of the world’s top biopharmaceutical...

November 3, 2021

Koneksa Completes $16M Series B Financing to Expand Digital Biomarker Platform

By Koneksa HealthNews

Koneksa will invest in the continued development of its digital platform for integrating wearables, sensors, and other technologies on a global scale. Financing round was led by Spring Mountain Capital...

September 28, 2020

Koneksa Health Announces Study Publication Validating mHealth Technologies in Early-Stage Clinical Trial Safety Monitoring

By Koneksa HealthNews

Wearable Devices Accurately Measure Heart Rate and Blood Pressure to Detect Drug Treatment Effects NEW YORK, Jan. 24, 2020 /PRNewswire/ — Koneksa Health, the leader in developing and implementing patient-focused digital...

January 24, 2020

Koneksa Health Announces New U.S. Office

By Koneksa HealthNews

NEW YORK, Nov. 6, 2019 /PRNewswire/ — Koneksa Health announced today the opening of its new corporate headquarters in New York. The company, which enables the biopharmaceutical industry to develop new medicines using...

November 6, 2019

Koneksa Health

Koneksa Announces Clinical Pipeline of Validated Digital Biomarkers to Accelerate Life Sciences Research

Koneksa Awarded a Grant from The Michael J. Fox Foundation to Evaluate Disease Progression Using Digital Measures in Parkinson’s Disease

Koneksa and Northwestern University Awarded a Grant from The Michael J. Fox Foundation to Investigate Speech Symptoms in Parkinson’s Disease

Aural Analytics and Koneksa Announce Partnership to Support Clinical Trials Using Speech Analytics

Koneksa Raises $45M Series C Financing to Accelerate Expansion of Digital Biomarker Platform

Koneksa Broadens Multi-Year CNS Research Collaboration with Sanofi Digital Clinical Trial Collaboration Expands to Multiple Sclerosis

Koneksa Completes $16M Series B Financing to Expand Digital Biomarker Platform

Koneksa Health Announces Study Publication Validating mHealth Technologies in Early-Stage Clinical Trial Safety Monitoring

Koneksa Health Announces New U.S. Office

Contact

Technical Support

Products

Solutions

Therapeutic Areas

Insights

Company

Search Koneksa